Q2SAR: A Quantum Multiple Kernel Learning Approach for Drug Discovery
This work addresses the problem of improving classification accuracy in cheminformatics for drug discovery, though it appears incremental as it builds on existing quantum and classical techniques.
The researchers tackled drug discovery by applying a Quantum Multiple Kernel Learning (QMKL) framework to QSAR classification, achieving a superior AUC score compared to classical methods on a DYRK1A kinase inhibitor dataset.
Quantitative Structure-Activity Relationship (QSAR) modeling is a cornerstone of computational drug discovery. This research demonstrates the successful application of a Quantum Multiple Kernel Learning (QMKL) framework to enhance QSAR classification, showing a notable performance improvement over classical methods. We apply this methodology to a dataset for identifying DYRK1A kinase inhibitors. The workflow involves converting SMILES representations into numerical molecular descriptors, reducing dimensionality via Principal Component Analysis (PCA), and employing a Support Vector Machine (SVM) trained on an optimized combination of multiple quantum and classical kernels. By benchmarking the QMKL-SVM against a classical Gradient Boosting model, we show that the quantum-enhanced approach achieves a superior AUC score, highlighting its potential to provide a quantum advantage in challenging cheminformatics classification tasks.